Ventura Joseph, Subotnik Kenneth L, Gitlin Michael J, Gretchen-Doorly Denise, Ered Arielle, Villa Kathleen F, Hellemann Gerhard S, Nuechterlein Keith H
UCLA Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA.
UCLA Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA.
Schizophr Res. 2015 Feb;161(2-3):407-13. doi: 10.1016/j.schres.2014.10.043. Epub 2014 Dec 8.
Understanding the longitudinal course of negative symptoms, especially in relationship to functioning, in the early phase of schizophrenia is crucial to developing intervention approaches. The course of negative symptoms and daily functioning was examined over a 1-year period following a recent onset of schizophrenia and at an 8-year follow-up point.
The study included 149 recent-onset schizophrenia patients who had a mean age of 23.7 (SD=4.4)years and mean education of 12.9 (SD=2.2)years. Negative symptom (BPRS and SANS) and functional outcome (SCORS) assessments were conducted frequently by trained raters.
After antipsychotic medication stabilization, negative symptoms during the first outpatient year were moderately stable (BPRS ICC=0.64 and SANS ICC=0.66). Despite this overall moderate stability, 24% of patients experienced at least one period of negative symptoms exacerbation. Furthermore, entry level of negative symptoms was significantly associated with poor social functioning (r=-.34, p<.01) and work/school functioning (r=-.25, p<.05) at 12months, and with negative symptoms at the 8-year follow-up (r=.29, p<.05).
Early negative symptoms are fairly stable during the first outpatient year, are predictors of daily functioning at 12months, and predict negative symptoms 8years later. Despite the high levels of stability, negative symptoms did fluctuate in a subsample of patients. These findings suggest that negative symptoms may be an important early course target for intervention aimed at promoting recovery.
了解精神分裂症早期阴性症状的纵向病程,尤其是其与功能的关系,对于制定干预方法至关重要。我们在精神分裂症近期发病后的1年期间以及8年随访点对阴性症状病程和日常功能进行了研究。
该研究纳入了149例近期发病的精神分裂症患者,他们的平均年龄为23.7(标准差=4.4)岁,平均受教育年限为12.9(标准差=2.2)年。由经过培训的评估者频繁进行阴性症状(简明精神病评定量表和阴性症状评定量表)和功能结局(社会和职业功能评定量表)评估。
在抗精神病药物稳定治疗后,门诊第一年的阴性症状呈中度稳定(简明精神病评定量表组内相关系数=0.64,阴性症状评定量表组内相关系数=0.66)。尽管总体上呈中度稳定,但24%的患者经历了至少一段阴性症状加重期。此外,阴性症状的初始水平与12个月时的社会功能差(r=-0.34,p<0.01)和工作/学习功能差(r=-0.25,p<0.05)显著相关,并且与8年随访时的阴性症状相关(r=0.29,p<0.05)。
早期阴性症状在门诊第一年相当稳定,是12个月时日常功能的预测指标,并且可预测8年后的阴性症状。尽管稳定性较高,但阴性症状在部分患者亚组中仍有波动。这些发现表明,阴性症状可能是旨在促进康复的早期干预的重要病程靶点。